3,421 reports of this reaction
3.1% of all LIDOCAINE 4% reports
#3 most reported adverse reaction
PRODUCT ADHESION ISSUE is the #3 most commonly reported adverse reaction for LIDOCAINE 4%, manufactured by Shenzhen Finona Information Technology Co., Ltd. There are 3,421 FDA adverse event reports linking LIDOCAINE 4% to PRODUCT ADHESION ISSUE. This represents approximately 3.1% of all 109,615 adverse event reports for this drug.
Patients taking LIDOCAINE 4% who experience product adhesion issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT ADHESION ISSUE is moderately reported among LIDOCAINE 4% users, representing a notable but not dominant share of adverse events.
In addition to product adhesion issue, the following adverse reactions have been reported for LIDOCAINE 4%:
The following drugs have also been linked to product adhesion issue in FDA adverse event reports:
PRODUCT ADHESION ISSUE has been reported as an adverse event in 3,421 FDA reports for LIDOCAINE 4%. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT ADHESION ISSUE accounts for approximately 3.1% of all adverse event reports for LIDOCAINE 4%, making it one of the most commonly reported side effect.
If you experience product adhesion issue while taking LIDOCAINE 4%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.